STOCK TITAN

Cardinal Health Inc - CAH STOCK NEWS

Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.

Overview

Cardinal Health (CAH) is a global integrated healthcare services and products company renowned for its capabilities in pharmaceutical distribution, healthcare supply chain management, and medical-surgical products. With over 50 years of operational experience, Cardinal Health has developed a comprehensive business model that connects patients, healthcare providers, pharmacists, and manufacturers, ensuring seamless care coordination across diverse healthcare settings.

Comprehensive Pharmaceutical and Medical-Surgical Distribution

At its core, Cardinal Health excels in sourcing, managing, and distributing branded, generic, and specialty pharmaceutical products to pharmacies, hospitals, ambulatory surgical centers, clinical laboratories, and physician offices globally. The company’s robust distribution network is designed to enhance operational efficiency and supply chain resiliency, ensuring that healthcare providers have timely access to essential medical products and equipment. This integrated approach not only improves patient management but also strengthens the efficiency of clinical care across a range of healthcare facilities.

Integrated Healthcare Solutions and Advanced Performance Tools

Beyond distribution, Cardinal Health is dedicated to delivering performance and data solutions that empower healthcare systems. The company offers cost-effective supply chain solutions, leveraging the latest in automated technology and analytics to optimize inventory management and logistical operations. This focus on performance-enhancing solutions demonstrates Cardinal Health’s commitment to operational excellence and improved patient outcomes.

Global Operations and Market Position

Operating in over 30 countries with a substantial global footprint, Cardinal Health is positioned among the top players in the healthcare and pharmaceutical sectors. The company serves a diverse and expansive customer base that includes hospital systems, independent pharmacies, and community-based healthcare providers. Its broad international presence reinforces its ability to adapt to local market dynamics while maintaining consistent operational standards worldwide.

Business Model and Strategic Initiatives

Cardinal Health generates revenue through multiple channels, including direct pharmaceutical sales, medical-surgical product distribution, and the provision of advanced data solutions that streamline healthcare logistics. Strategic investments in new logistics centers, integration of automated inventory management systems, and the recent incorporation of specialty platforms illustrate the company’s multi-faceted growth strategy. These initiatives are part of its long-standing commitment to providing comprehensive and efficient healthcare solutions that add value for both providers and patients.

Key Differentiators

Several factors underscore Cardinal Health’s significance in its industry:

  • Integrated Supply Chain Solutions: A robust network that connects various stakeholders in the healthcare ecosystem.
  • Advanced Technology and Analytics: Deployment of automated logistics and performance systems to enhance operational efficiency.
  • Global Reach: A wide geographic presence that ensures consistent quality and responsiveness to customer needs.
  • Specialty Services: Focus on tailored pharmaceutical and specialty solutions to support community-based practices.

Commitment to Quality and Efficiency

Cardinal Health’s enduring legacy of expertise, earned over nearly a century, underscores its ability to integrate complex supply-chain dynamics with innovative performance solutions. This establishes the company as a reliable partner in healthcare, consistently driving improvements in service delivery and patient care.

Conclusion

In summary, Cardinal Health is not only a major distributor in the pharmaceutical industry but also a comprehensive service provider that plays a pivotal role in the healthcare supply chain. Its integrated approach, advanced technological capabilities, and global operational strength make it a cornerstone of efficient healthcare delivery in diverse clinical settings.

Rhea-AI Summary

Cardinal Health (NYSE: CAH) announced an irrevocable early redemption notice for its outstanding notes, totaling $500 million, due June 2022. The affected notes include $237.56 million at a rate of 3.200% and $262.44 million at 2.616%. The redemption date is set for June 15, 2021. The redemption prices will be determined based on specific terms outlined in the indentures, ensuring holders receive the greater of principal or present values of remaining payments. This move reflects Cardinal Health's strategy to manage debt effectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.43%
Tags
none
-
Rhea-AI Summary

Cardinal Health (CAH) reported Q3 FY21 revenue of $39.3 billion, matching last year’s performance. However, GAAP operating earnings fell 16% to $473 million, influenced by a write-down related to the Cordis divestiture. Diluted EPS dropped to $0.40 due to a litigation tax effect. Non-GAAP operating earnings decreased 4% to $689 million, largely from COVID-19 impacts on the Pharmaceutical segment. The company narrowed its fiscal year 2021 EPS guidance to $5.90 to $6.05.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.05%
Tags
-
News
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has launched Outcomes, a digital ecosystem aimed at improving medication adherence by linking pharmacists, payers, and pharmaceutical companies. This initiative addresses the $528 billion annual cost of medication non-adherence in the U.S., which results in around 275,000 avoidable deaths each year. The Connect platform, part of Outcomes, integrates various existing Cardinal Health services and supports over 60,000 pharmacies and 23 million patients, enhancing clinical workflows and patient engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
none
Rhea-AI Summary

On April 13, 2021, Cardinal Health (NYSE: CAH) announced it secured a $57.8 million contract with the U.S. Department of Health and Human Services for the storage and distribution of 80,000 pallets of personal protective equipment (PPE). This contract has the potential to reach $91.6 million if all options are exercised. Cardinal Health's extensive distribution network will enable rapid delivery of PPE to healthcare providers across the U.S. in response to ongoing public health emergencies, including the COVID-19 pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has launched Cardinal Health™ Navista™ Tech Solutions (TS), designed to assist community oncologists in enhancing patient care and minimizing costs during the shift to value-based care. This suite includes integrated AI-enabled solutions such as Episode Analytics for cost tracking, CureMD Oncology Cloud for practice management, and CORE™ for population health support. By offering these tools, Cardinal Health aims to improve decision-making, automate processes, and reduce administrative burdens, ultimately driving better patient outcomes and financial performance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.76%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) will release its financial results for Q3 fiscal year 2021 on May 6, before market opening. A webcast discussing these results will begin at 8:30 a.m. Eastern. The company specializes in distribution of pharmaceuticals and medical products, serving healthcare facilities globally, with operations in over 40 countries and approximately 48,000 employees. Interested parties can access the webcast and presentation on the Investor Relations page.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.29%
Tags
conferences earnings
Rhea-AI Summary

Cardinal Health (CAH) has signed an agreement to sell its Cordis business to Hellman & Friedman for approximately $1 billion. The divestiture, expected to close in the first half of fiscal year 2022, will decrease Cardinal Health's Medical segment profit by $60 million to $70 million annually. The company anticipates a pre-tax loss of up to $120 million for Q3 of fiscal year 2021 related to this transaction. Cardinal Health retains liability for certain lawsuits associated with Cordis post-sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.93%
Tags
none
-
Rhea-AI Summary

On February 18, 2021, Cardinal Health announced a partnership with HIMSS Analytics as a certified organization for the Clinically Integrated Supply Outcomes Model (CISOM). This collaboration aims to enhance healthcare supply chain management and minimize medical errors. WaveMark™ Supply Management & Workflow Solutions will assist health systems in evaluating their supply chain maturity, facilitating automation, and improving patient care efficiency. Key benefits include automated tracking for recalls, cost savings insights, and comprehensive supply documentation, aiming for better patient outcomes at lower costs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.68%
Tags
none
-
Rhea-AI Summary

Cardinal Health reported Q2 FY21 revenue of $41.5 billion, a 5% increase year-over-year. Operating earnings rose 38% to $461 million, primarily benefiting from a prior-year charge related to surgical gown recalls. GAAP diluted EPS increased to $2.13, while non-GAAP diluted EPS rose 14% to $1.74. The Pharmaceutical segment saw a 4% revenue increase, but segment profit dropped 11% due to COVID-19 impacts. In contrast, the Medical segment's revenue grew 7%, with profits up 21%. Cardinal Health raised its FY21 EPS guidance to $5.85-$6.10.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.07%
Tags
Rhea-AI Summary

Cardinal Health (NYSE: CAH) launched TotalVue™ Analytics, a predictive tool for healthcare supply chain leaders to identify logistics savings and benchmark performance. This tool enhances visibility into shipping trends, helping health systems reduce freight costs. With machine learning capabilities, it enables precise benchmarking by comparing similar hospital systems. Early users like Banner Health reported substantial cost savings by improving shipping management. The tool aims to provide actionable data and long-term efficiencies in logistics management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.36%
Tags
none

FAQ

What is the current stock price of Cardinal Health (CAH)?

The current stock price of Cardinal Health (CAH) is $137.13 as of April 1, 2025.

What is the market cap of Cardinal Health (CAH)?

The market cap of Cardinal Health (CAH) is approximately 33.5B.

What is Cardinal Health's core business?

Cardinal Health is a global integrated healthcare services and products company. It focuses on pharmaceutical distribution, medical-surgical product supply, and performance-driven supply chain solutions.

How does Cardinal Health generate revenue?

The company generates revenue through direct sales of pharmaceutical products, distribution of medical-surgical supplies, and innovative performance solutions that enhance supply chain efficiency across healthcare facilities.

What industries does Cardinal Health serve?

Cardinal Health serves a wide range of industries including hospitals, pharmacies, ambulatory surgical centers, clinical laboratories, and physician offices, operating across diverse global markets.

What makes Cardinal Health's distribution network unique?

Their integrated supply chain network connects patients, providers, payers, and manufacturers, utilizing advanced logistics technology and automated inventory management systems to ensure timely and efficient delivery of products.

In what ways does Cardinal Health use technology to enhance its operations?

The company leverages automated systems, advanced analytics, and performance data solutions to optimize inventory management and improve supply chain resiliency, thereby enhancing the overall healthcare delivery process.

How does Cardinal Health support community-based healthcare providers?

Besides offering robust pharmaceutical and medical product distribution, Cardinal Health provides specialty solutions and practice management services, helping community-based providers deliver high-quality, cost-effective patient care.

What is Cardinal Health's market position in the healthcare industry?

With a strong global footprint and decades of operational expertise, Cardinal Health is among the top players in pharmaceutical and medical-surgical distribution, ensuring reliable, high-quality healthcare solutions worldwide.

How does Cardinal Health maintain supply chain resiliency?

They continuously invest in infrastructure enhancements, technology integration, and strategic logistics initiatives, all designed to optimize inventory flow and adapt to dynamic market demands.
Cardinal Health Inc

NYSE:CAH

CAH Rankings

CAH Stock Data

33.50B
240.93M
0.25%
89.03%
2.68%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States
DUBLIN